| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.22 | 3e-05 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.25 | 4e-05 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.21 | 4e-05 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.13 | 5e-05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.13 | 8e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.12 | 8e-05 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.11 | 8e-05 |